USANA Health Sciences, Inc.
Consumer Defensive sector | Packaged Foods industry
Metrics for USNA
| Price | $18.88 |
|---|---|
| Shares Outstanding | 18.46M |
| All-Time Low | $0.05 |
| 52-Week Low | $18.48 |
Balance Statement Metrics
| Net Cash / Share | $1.01 |
|---|---|
| Net Current Assets / Share | $8.13 |
| Net Tangible Assets / Share | $17.75 |
| Shares Outstanding Ave Change (Annual) | -0.57% |
| Shares Δ YoY | -0.35% |
| Avg CA Burn (Annual %) | -6.40% (as of 5-24-2026) |
| Avg CA Burn (Quarterly %) | 1.29% (as of 5-24-2026) |
Earning Metrics
| Max Earning Power / Share | $13.15 |
|---|---|
| Adjusted Earning Power |
$3.59
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
2.66%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 136.3M (as of 5-24-2026) |
| Avg EBITDA (5Q) | 21.5M (as of 5-24-2026) |
| Avg Net Income (5Y) | 72.9M (as of 5-24-2026) |
| Avg Net Income (5Q) | 3.5M (as of 5-24-2026) |
Indicators
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 5-24-2026 |
| Consecutive Years Paid | No | 5-24-2026 |
| Pays Dividend | No | 5-24-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 5-24-2026 |
| Net Income Positive | Yes | 5-24-2026 |
| Current Dividend Streak | No | 5-24-2026 |
Metric History Explorer
Pick a metric to view its history table and chart.
Tangible Book Value Per Share History
Formula: Tangible Book Value / shares from balance statements. Includes 7 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2026-03-31 | Quarterly | $14.98 | 276.5M ($276,522,000) | 18.5M (18,456,935) |
| 2025-12-31 | Quarterly | $14.33 | 262M ($261,991,000) | 18.3M (18,280,857) |
| 2025-09-30 | Quarterly | $13.44 | 245.6M ($245,627,000) | 18.3M (18,272,000) |
| 2025-06-30 | Quarterly | $13.37 | 244.1M ($244,083,000) | 18.3M (18,262,000) |
| 2025-03-31 | Quarterly | $12.69 | 238.4M ($238,387,000) | 18.8M (18,786,000) |
| 2024-12-31 | Quarterly | $12.39 | 236.1M ($236,118,000) | 19.1M (19,064,000) |
| 2024-12-31 | Annual | $12.39 | 236.1M ($236,118,000) | 19.1M (19,064,000) |
| 2024-09-30 | Quarterly | $25.54 | 486.7M ($486,654,000) | 19.1M (19,056,000) |
| 2023-12-31 | Annual | $23.53 | 450.2M ($450,181,000) | 19.1M (19,130,000) |
| 2022-12-31 | Annual | $20.03 | 384.7M ($384,672,000) | 19.2M (19,206,000) |
| 2021-12-31 | Annual | $17.89 | 347M ($347,014,000) | 19.4M (19,393,000) |
Revenue History (Annual)
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 854.5M ($854,503,000) |
| 2023-12-31 | 921M ($921,010,000) |
| 2022-12-31 | 998.6M ($998,601,000) |
| 2021-12-31 | 1.2B ($1,186,464,000) |
Dividend Payments
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
Shares Outstanding Changes
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-05-13 | 18,463,011 | +6,076 |
| 2026-03-19 | 18,456,935 | +176,078 |
Short Interest Changes
Latest short-interest change: 640,532 shares (5.87% of float) | Days to cover: 5.40
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-06-10 | 640,532 shares | +44,680 | +7.50% |
| 2026-05-28 | 595,852 shares | +93,936 | +18.72% |
| 2026-05-14 | 501,916 shares | +24,037 | +5.03% |
| 2026-04-27 | 477,879 shares | -53,744 | -10.11% |
| 2026-04-13 | 531,623 shares | +78,052 | +17.21% |
| 2026-03-24 | 453,571 shares | +50,690 | +12.58% |
| 2026-03-11 | 402,881 shares | -12,709 | -3.06% |
| 2026-02-26 | 415,590 shares | -66,218 | -13.74% |
| 2026-02-11 | 481,808 shares | -16,972 | -3.40% |
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.